Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Arginine and Vasodilator Agents

Research Papers that Mention the Interaction

Long-term oral therapy with L-arginine reduced endothelial dysfunction and inhibited the development of atherosclerosis, but the mechanisms by which it exerts its vasodilator effect are not completely understood.
The Lancet  •  1997  |  View Paper
Our findings suggest that a vasodilator effect of NO induced by L-arginine loading may, at least in part, be associated with increased renal sodium excretion in patients with chronic renal failure.
Nihon Jinzo Gakkai shi  •  2000  |  View Paper
Systemic infusion of L-arginine induced renal vasodilation and natriuresis in normotensive subjects, an effect which seems to be mediated mainly by intrarenal NO production.
Journal of nephrology  •  1997  |  View Paper
L-arginine … vasodilator response to acetylcholine in control subjects (maximum flow decreased from 16.4±8 to 7.01±3 mL min'1 100 mL1; p<0.… alter the response to acetylcholine in hypertensive patients (maximum flow, 8.2+4 versus 8.01±5 mL. min1 100 mL'1).
Circulation  •  1993  |  View Paper
Release of this vasodilator was enhanced by arginine analogs, including Nω-nitro-l-arginine (a NO synthase inhibitor), suggesting that it is not NO.
Proceedings of the National Academy of Sciences  •  2008  |  View Paper
In conclusion, renal vasodilation is more sensitive to L-arginine during salt restriction.
Infusion of L-arginine , the substrate for nitric oxide synthase, causes renal vasodilation.
Hypertension  •  1995  |  View Paper
Concomitant infusion of L-arginine prevented the inhibitory effect of L-NNA on renal vasodilation induced by intrarenal infusion of AVP in the presence of the V1-antagonist.
Journal of cardiovascular pharmacology  •  1994  |  View Paper
In control rats, L-arginine infusion induced a vasodilatory response of AR and ER, and elevation of QA and Kf, which resulted in a 72.6% increase in SNGFR.
Kidney international  •  1994  |  View Paper
Production of the vasorelaxant was enhanced by 0.5 mM L-arginine and inhibited reversibly by NG-methylated L-arginine analogs that block macrophage NO2-/NO3- synthesis.
The Journal of experimental medicine  •  1989  |  View Paper